Stock INAB IN8BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart IN8bio, Inc.

Equities

INAB

US45674E1091

Delayed Nasdaq
Other stock markets
 20:51:04 24/05/2024 BST 		5-day change 1st Jan Change
1.01 USD -2.88% Intraday chart for IN8bio, Inc. -1.95% -26.82%
11:58am IN8bio Plans to Report Improvement in Progression-Free Survival of Newly Diagnosed Patients With Glioblastoma Multiforme MT
05-13 HC Wainwright Adjusts Price Target on IN8bio to $12.50 From $14, Keeps Buy Rating MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
IN8BIO, INC.
Bio Therapeutic Drugs
-2.88%-1.95%-26.82%-61.16% - 45.78M
Neutral
Neutral
Neutral
  1. Stock Market
  2. Equities
  3. INAB Stock
  4. Charts IN8bio, Inc.
  5. Relative Strength Chart